Atea Pharmaceuticals (AVIR) Short Interest Ratio & Short Volume $3.44 -0.05 (-1.43%) As of 02:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Atea Pharmaceuticals Short Interest DataAtea Pharmaceuticals (AVIR) has a short interest of 4.46 million shares, representing 6.94% of the float (the number of shares available for trading by the public). This marks a 2.76% increase in short interest from the previous month. The short interest ratio (days to cover) is 11.1, indicating that it would take 11.1 days of the average trading volume of 384,342 shares to cover all short positions.Current Short Interest4,460,000 sharesPrevious Short Interest4,340,000 sharesChange Vs. Previous Month+2.76%Dollar Volume Sold Short$16.23 millionShort Interest Ratio11.1 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares79,360,000 sharesFloat Size64,310,000 sharesShort Percent of Float6.94%Today's Trading Volume228,966 sharesAverage Trading Volume384,342 sharesToday's Volume Vs. Average60% Short Selling Atea Pharmaceuticals? Sign up to receive the latest short interest report for Atea Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAVIR Short Interest Over TimeAVIR Days to Cover Over TimeAVIR Percentage of Float Shorted Over Time Atea Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20254,460,000 shares $16.23 million +2.8%6.9%11.1 $3.64 7/15/20254,340,000 shares $15.49 million +13.9%6.3%10.1 $3.57 6/30/20253,810,000 shares $13.72 million +14.8%5.5%8.7 $3.60 6/15/20253,320,000 shares $10.49 million +8.5%4.8%8 $3.16 5/31/20253,060,000 shares $9.12 million -5.6%4.4%7.8 $2.98 5/15/20253,240,000 shares $8.39 million +6.2%4.8%8.6 $2.59 4/30/20253,050,000 shares $9.00 million +2.7%4.5%8.7 $2.95 4/15/20252,970,000 shares $8.38 million -1.3%4.4%8.7 $2.82 3/31/20253,010,000 shares $9.00 million +3.4%4.5%8.9 $2.99 3/15/20252,910,000 shares $8.96 million +1.4%4.2%7.6 $3.08 Get the Latest News and Ratings for AVIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/28/20252,870,000 shares $8.70 million -2.7%4.1%6.7 $3.03 2/15/20252,950,000 shares $9.29 million No Change4.0%7.3 $3.15 1/31/20252,950,000 shares $9.03 million +3.5%4.0%7.4 $3.06 1/15/20252,850,000 shares $9.46 million +2.9%3.9%8 $3.32 12/31/20242,770,000 shares $9.28 million -12.9%3.7%9 $3.35 12/15/20243,180,000 shares $9.32 million +21.8%4.3%11.9 $2.93 11/30/20242,610,000 shares $8.93 million -1.1%3.5%11.9 $3.42 11/15/20242,640,000 shares $8.50 million +1.9%3.6%13.9 $3.22 10/31/20242,590,000 shares $8.39 million -1.5%3.5%13.1 $3.24 10/15/20242,630,000 shares $9.34 million -5.4%3.6%12.9 $3.55 9/30/20242,780,000 shares $9.31 million +3.0%3.8%12.8 $3.35 9/15/20242,700,000 shares $10.45 million -4.6%3.7%11.4 $3.87 8/31/20242,830,000 shares $10.90 million +13.7%3.8%12.1 $3.85 8/15/20242,490,000 shares $9.31 million +4.6%3.4%10.2 $3.74 7/31/20242,380,000 shares $9.09 million +0.4%3.2%9.2 $3.82 7/15/20242,370,000 shares $8.39 million +5.8%3.2%9.1 $3.54 6/30/20242,240,000 shares $7.41 million +5.2%3.0%8.7 $3.31 6/15/20242,130,000 shares $7.69 million -2.3%2.9%8.1 $3.61 5/31/20242,180,000 shares $8.00 million +16.6%3.0%7.6 $3.67 5/15/20241,870,000 shares $6.94 million +3.9%2.5%6 $3.71 4/30/20241,800,000 shares $6.66 million +2.9%2.4%5.2 $3.70 4/15/20241,750,000 shares $6.58 million +4.8%2.4%4.3 $3.76 3/31/20241,670,000 shares $6.75 million -1.8%2.3%3.6 $4.04 3/15/20241,700,000 shares $6.82 million +3.0%2.3%3.6 $4.01 2/29/20241,650,000 shares $7.11 million +1.9%2.2%3.4 $4.31 2/15/20241,620,000 shares $6.82 million -57.4%2.2%3.4 $4.21 1/31/20243,800,000 shares $15.81 million +1.9%5.2%8.1 $4.16 1/15/20243,730,000 shares $13.28 million -1.1%5.1%8.3 $3.56 12/31/20233,770,000 shares $11.50 million +7.1%5.1%9.1 $3.05 12/15/20233,520,000 shares $10.38 million -1.1%4.8%8.6 $2.95This stock could leave NVDA in the dust (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here. 11/30/20233,560,000 shares $10.64 million -1.7%4.9%8.8 $2.99 11/15/20233,620,000 shares $10.68 million +31.2%4.9%9.2 $2.95 10/31/20232,760,000 shares $8.97 million +15.0%3.8%7.2 $3.25 10/15/20232,400,000 shares $7.27 million +34.1%3.3%6.7 $3.03 9/30/20231,790,000 shares $5.37 million -6.8%2.4%5.3 $3.00 9/15/20231,920,000 shares $6.11 million +8.5%2.6%5.5 $3.18 8/31/20231,770,000 shares $5.95 million +4.7%2.4%5 $3.36 8/15/20231,690,000 shares $5.66 million -9.1%2.3%3.3 $3.35 7/31/20231,860,000 shares $6.38 million +1.6%2.5%2.8 $3.43 7/15/20231,830,000 shares $6.66 million +9.6%2.5%2.6 $3.64 6/30/20231,670,000 shares $6.25 million -8.2%2.3%2.3 $3.74 6/15/20231,820,000 shares $7.55 million -2.7%2.5%2.4 $4.15 5/31/20231,870,000 shares $7.46 million +9.4%2.6%2.3 $3.99 5/15/20231,710,000 shares $5.90 million -11.9%2.3%2.4 $3.45 4/30/20231,940,000 shares $6.34 million +2.1%2.7%3.5 $3.27 4/15/20231,900,000 shares $6.23 million +6.2%2.6%3.5 $3.28 3/31/20231,790,000 shares $6.00 million -5.8%2.5%3.4 $3.35 3/15/20231,900,000 shares $6.94 million +5.6%2.6%3.7 $3.65 2/28/20231,800,000 shares $6.37 million +20.0%2.5%4.2 $3.54 2/15/20231,500,000 shares $6.14 million +1.4%2.1%3.6 $4.09 1/31/20231,480,000 shares $6.85 million -10.8%2.0%3.2 $4.63 1/15/20231,660,000 shares $8.18 million -0.6%2.3%3.6 $4.93 12/30/20221,670,000 shares $8.03 million -14.8%2.3%3.6 $4.81 12/15/20221,960,000 shares $8.60 million +3.2%2.7%4.1 $4.39 11/30/20221,900,000 shares $8.91 million -3.1%2.6%3.8 $4.69 11/15/20221,960,000 shares $10.15 million -13.7%2.7%3.9 $5.18 10/31/20222,270,000 shares $13.62 million -1.3%3.1%4.7 $6.00 10/15/20222,300,000 shares $12.08 million +4.1%3.1%5.2 $5.25 9/30/20222,210,000 shares $12.57 million -3.9%3.0%5 $5.69 9/15/20222,300,000 shares $15.76 million -12.9%3.1%4.9 $6.85 8/31/20222,640,000 shares $19.80 million -4.0%3.6%5.3 $7.50 8/15/20222,750,000 shares $23.60 million +1.1%3.8%4.8 $8.58 7/31/20222,720,000 shares $22.30 million -6.5%3.7%4 $8.20 7/15/20222,910,000 shares $23.57 million +10.7%4.0%4.2 $8.10 6/30/20222,630,000 shares $18.67 million +30.2%3.6%3.7 $7.10 6/15/20222,020,000 shares $13.33 million +4.1%2.8%2.7 $6.60 5/31/20221,940,000 shares $15.29 million -18.8%2.7%2.5 $7.88 5/15/20222,390,000 shares $17.42 million +21.9%3.3%2.9 $7.29 4/30/20221,960,000 shares $11.51 million +10.7%2.7%2.2 $5.87 4/15/20221,770,000 shares $11.66 million -15.3%2.5%1.8 $6.59 3/31/20222,090,000 shares $15.09 million -27.2%2.9%2 $7.22 3/15/20222,870,000 shares $16.33 million +11.2%4.0%2.5 $5.69 2/28/20222,580,000 shares $16.36 million +2.8%3.6%2 $6.34 2/15/20222,510,000 shares $16.11 million -20.1%3.5%1.8 $6.42 1/31/20223,140,000 shares $22.42 million +13.0%5.1%1.8 $7.14 1/15/20222,780,000 shares $20.29 million +6.9%4.5%1.4 $7.30 12/31/20212,600,000 shares $23.24 million +6.6%4.2%0.6 $8.94 12/15/20212,440,000 shares $19.52 million +29.8%3.9%0.5 $8.00 11/30/20211,880,000 shares $15.21 million -69.8%3.0%0.4 $8.09 11/15/20216,230,000 shares $71.65 million -0.6%10.0%1.3 $11.50This stock could leave NVDA in the dust (Ad)Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.Click to get the full details on Eric Fry's "Nvidia alternative" right here. 10/29/20216,270,000 shares $72.98 million +17.2%10.5%1.4 $11.64 10/15/20215,350,000 shares $210.15 million -17.3%8.9%1.3 $39.28 9/30/20216,470,000 shares $226.84 million +26.4%10.8%3.7 $35.06 9/15/20215,120,000 shares $133.02 million +0.6%8.8%3.7 $25.98 8/31/20215,090,000 shares $151.27 million -12.8%8.9%3.7 $29.72 8/13/20215,840,000 shares $161.59 million +9.2%10.6%4.4 $27.67 7/30/20215,350,000 shares $133.96 million -24.3%9.7%4.1 $25.04 7/15/20217,070,000 shares $155.61 million -18.6%12.9%5.1 $22.01 6/30/20218,690,000 shares $186.66 million +72.1%15.8%6.5 $21.48 6/15/20215,050,000 shares $119.08 million No Change9.2%5 $23.58 5/28/20215,050,000 shares $103.12 million +0.6%9.2%6.4 $20.42 5/14/20215,020,000 shares $96.48 million +5.5%9.1%7.2 $19.22 4/30/20214,760,000 shares $125.57 million +12.0%8.4%8 $26.38 4/15/20214,250,000 shares $231.97 million +36.7%9.3%12.2 $54.58 3/31/20213,110,000 shares $174.88 million +38.8%6.8%9.9 $56.23 3/15/20212,240,000 shares $152.01 million +34.9%4.9%6.8 $67.86 2/26/20211,660,000 shares $134.94 million +1.2%3.6%5 $81.29 2/12/20211,640,000 shares $144.19 million -27.8%3.7%5.3 $87.92 1/29/20212,270,000 shares $134.25 million No Change4.8%5.8 $59.14 1/15/20212,270,000 shares $118.27 million No Change4.8%4.8 $52.10 AVIR Short Interest - Frequently Asked Questions What is Atea Pharmaceuticals' current short interest? Short interest is the volume of Atea Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 4,460,000 shares of AVIR short. 6.94% of Atea Pharmaceuticals' shares are currently sold short. Learn More on Atea Pharmaceuticals' current short interest. What is a good short interest ratio for Atea Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVIR shares currently have a short interest ratio of 11.0. Learn More on Atea Pharmaceuticals's short interest ratio. What is a good short interest percentage for Atea Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.94% of Atea Pharmaceuticals' floating shares are currently sold short. Is Atea Pharmaceuticals' short interest increasing or decreasing? Atea Pharmaceuticals saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 4,460,000 shares, an increase of 2.8% from the previous total of 4,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Atea Pharmaceuticals' float size? Atea Pharmaceuticals currently has issued a total of 79,360,000 shares. Some of Atea Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Atea Pharmaceuticals currently has a public float of 64,310,000 shares. How does Atea Pharmaceuticals' short interest compare to its competitors? 6.94% of Atea Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Atea Pharmaceuticals: Pharvaris N.V. (1.98%), Verve Therapeutics, Inc. (5.52%), LENZ Therapeutics, Inc. (16.64%), Praxis Precision Medicines, Inc. (11.26%), Arcus Biosciences, Inc. (13.81%), Anavex Life Sciences Corp. (32.78%), Structure Therapeutics Inc. Sponsored ADR (13.14%), Spyre Therapeutics, Inc. (25.08%), Akebia Therapeutics, Inc. (9.54%), Pharming Group N.V. Sponsored ADR (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), MicroStrategy Incorporated ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Atea Pharmaceuticals stock? Short selling AVIR is an investing strategy that aims to generate trading profit from Atea Pharmaceuticals as its price is falling. AVIR shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Atea Pharmaceuticals? A short squeeze for Atea Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AVIR, which in turn drives the price of the stock up even further. How often is Atea Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVIR, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Pharvaris Short Interest Verve Therapeutics Short Interest LENZ Therapeutics Short Interest Praxis Precision Medicines Short Interest Arcus Biosciences Short Interest Anavex Life Sciences Short Interest Structure Therapeutics Short Interest Spyre Therapeutics Short Interest Akebia Therapeutics Short Interest Pharming Group Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AVIR) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access